ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 42 filers reported holding ASLAN PHARMACEUTICALS LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,747,000 | -20.8% | 1,941,219 | -1.5% | 0.03% | 0.0% |
Q4 2021 | $2,206,000 | -37.1% | 1,970,000 | 0.0% | 0.03% | -28.2% |
Q3 2021 | $3,507,000 | -57.8% | 1,970,000 | -21.8% | 0.04% | -53.6% |
Q2 2021 | $8,316,000 | -1.5% | 2,520,000 | 0.0% | 0.08% | +6.3% |
Q1 2021 | $8,442,000 | – | 2,520,000 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |